Sekar Kathiresan, MD, sits down with me to discuss his unique career path from esteemed cardiologist and physician-geneticist at Massachusetts General Hospital to co-founder and CEO of Verve Therapeutics.
Dr. Kathiresan discovered a way to predict risk of developing heart attacks even in patients who don’t possess risk factors. He founded this startup to discover ways to counter premature heart attacks. You’ll really want to hear what he has to say.
This podcast is produced by the Journal of Clinical Pathways.
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
